MSB 2.08% 94.0¢ mesoblast limited

Ann: Update on Novartis Agreement, page-95

  1. 4,670 Posts.
    lightbulb Created with Sketch. 717
    Col, sshhh you're thinking......ARDS is no more dead than the heart program was, when TEVA walked........it may shock many to know, Novartis is not the only silverback in the bio-pharma cage....perish the thought the Prof is already on the ph inviting another to dance!

    After last week's data he won't want for suitors.......what people are AGAIN experiencing is the frustration of requiring more patience to see the returns they want! And that's tough for ALL of us....but, not a single program is dead!

    Companies like Novartis, TEVA and others sign into and exit from exploratory deals all the time, for whatever reason, MSB has the goods, it just needs to arrange the deck-chairs right....OTAT is the starting point.

    ARDS didn't exist to MSB just 20mths or so ago!!!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
94.0¢
Change
-0.020(2.08%)
Mkt cap ! $1.073B
Open High Low Value Volume
95.5¢ 97.0¢ 93.5¢ $1.424M 1.507M

Buyers (Bids)

No. Vol. Price($)
8 29390 93.5¢
 

Sellers (Offers)

Price($) Vol. No.
94.5¢ 14089 2
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.